Table 3 Median age at diagnosis and interquartile range (IQR) in de novo patients in each diagnostic category by constitutional, mosaic/presumed mosaic and no pathogenic variant found

From: Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing

 

Full constitutional path_variant

Mosaic/presumed mosaic

Pathogenic variant not found

 

De novo category

n

Median age at diagnosis

IQR

n

Median age at diagnosis

IQR

n

Median age at diagnosis

IQR

p value

Bilateral VS no FH

303

21

15.0–34.0

122

31

22.0–42.25

255

48

30–62

<0.001

BVS UVS first

18

29.5

18.5–38.5

12

32

19.25–55.25

39

48

30–61

0.003

UVS + 2 schwannomas

5

13

8.0–34.0

18

36

20.75–47.0

29

41

33.5–52.0

0.016

UVS + 2 other

18

37

23.75–60.25

39

42

32.0–49.0

91

47

36.0–58.0

0.044

≥2 meningioma + 2 other

13

16

8.5–20.75

4

49.5

47.25–57.75

15

35

26.0–48.0

<0.001

Pathogenic variant + 1 tumor

11

8

4.0–15.0

2

2.5

2.0–2.5

0

  

0.231

Pathogenic variant + 2 tumors

3

9

2.0–9.0

5

32

11.0–40.5

0

  

0.143

Schwannomatosis NF2 mosaic

0

  

9

44

25.0–51.5

0

  

n/a

UVS + sibling NF2

0

     

0

   

UVS + child NF2

0

  

1

50

n/a

1

44

 

n/a

≥2 Meningioma child NF2

0

  

0

  

6

35.5

25.75–44.5

n/a

Ocular + pathogenic variant

0

  

1

1

n/a

0

  

n/a

Total

371

21

15.0–34.0

213

35

23.0–47.0

435

32

32.0–60.0

<0.001

  1. BVS bilateral vestibular schwannoma, FH family history, NF2 neurofibromatosis type 2, PPV positive predictive value, UVS unilateral vestibular schwannoma, VS vestibular schwannoma.